RCKT

Rocket Pharmaceuticals, Inc.

3 catalysts on file

RCKT

Rocket Pharmaceuticals, Inc.

PDUFA Confirmed

KRESLADI

severe leukocyte adhesion deficiency-I (LAD-I)

146d ago Mar 28, 2026

SEC 8-K verified 2mo ago

RCKT

Rocket Pharmaceuticals, Inc.

Phase 2 AI-extracted

RP-A501

Danon disease

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

RCKT

Rocket Pharmaceuticals, Inc.

Phase 1 AI-extracted

RP-A701

BAG3-associated dilated cardiomyopathy (BAG3-DCM)

T-minus 10 days ~ Aug 31, 2026

SEC 8-K verified 2mo ago